These results showed that AS/LIG/AS_LIG@PPGC NPs could modulate the NOX4/NLRP3/p38 MAPK signaling pathway in IPF, thereby alleviating pulmonary inflammation and fibrosis levels. This evidence concerns the gene NOX4 and idiopathic pulmonary fibrosis.